# A Study Looking at the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients With Sepsis (Limiting AKI Progression In Sepsis)

> **NCT04434209** · NA · TERMINATED · sponsor: **BioMérieux** · enrollment: 19 (actual)

## Conditions studied

- Sepsis
- Acute Kidney Injury
- Septic Shock

## Interventions

- **DEVICE:** Subject management guided by NephroCheck® test
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT04434209
- **Lead sponsor:** BioMérieux
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-19
- **Primary completion:** 2022-02-14
- **Final completion:** 2022-02-14
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Highly improbable to reach recruitment objective due to impact of COVID-19 pandemic
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04434209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04434209, "A Study Looking at the Use of Biomarkers to Provide Early Indication of Acute Kidney Injury in Patients With Sepsis (Limiting AKI Progression In Sepsis)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04434209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*